Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)
Tamsulosin Hydrochloride Capsule
Product Images NDC 65862-598
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 65862-598). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)
Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)
This appears to be a graph showing the mean change in Total AUA Symptom Score for three different treatments (0.2mg, 0.4mg, and placebo) over a period of up to 13 weeks. The x-axis indicates the duration of treatment in weeks and the y-axis shows the mean change from baseline. The graph appears to be from "Study 2".*
Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
This is a graph labeled "Figure 3A" that compares the mean increase in peak urine flow rate between three different treatments over a duration of weeks. The treatments are represented by different symbols and include 0.08mg, 2x 0.4mg, and placebo. The y-axis shows the mean change in mL/sec, and the x-axis shows the duration of the treatment in weeks. There are also labels for the number of participants in each treatment group.*
Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
This is a graph showing the mean increase in peak urine flow rate in mL/Sec in Study 2. The x-axis represents the duration of treatment in weeks and the y-axis represents the increase in peak urine flow rate. The graph depicts the results of a treatment, but further information or context is not available.*
Package Label-principal Display Panel (0.4 mg (100 Capsule Bottle))
This text describes Tamsulosin Hydrochloride Capsules, a medication available through prescription for treating certain urinary problems in men. Each capsule contains 0.4mg of Tamsulosin Hydrochloride USP. The typical dose is described as per accompanying prescription details. It advises to store in a dry and tight container at room temperature (20°C-25°C) and avoid moisture. The medicine should not be taken without a doctor's prescription. Distributed by Aurobindo Pharma USA, Inc., this medication is manufactured in India.*
Package Label-principal Display Panel (0.4 mg Blister Carton (3 x 10 Unit-dose))
This is a medication description for Tamsulosin Hydrochloride that comes in 30 capsules. The capsules are only available with a prescription and are made by AUROBINDO. Each capsule contains 0.4mg of Tamsulosin hydrochloride USP. The rest of the text appears to be output and is not readable.*
Chemical Structure (Tamsulosin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
